long intergenic non-protein coding RNA 2499Genealiases: []
Q-omics provides the consensus-scored LINC02499 profile across patient tissues and cancer cell-line models. LINC02499 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02499 is differentially expressed in 10, with the highest sampling consensus in KIRC. Additionally, LINC02499 RNA expression shows 9,426 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KICH, KIRC, and TGCT as cancer lineages where LINC02499 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02499 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02499 survival associations across molecular data types. LINC02499 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02499 RNA expression–survival associations across cancer types. High LINC02499 expression shows unfavorable associations in KICH, CHOL, LGG and THYM, but favorable associations in LIHC and KIRC. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02499 RNA expression.
This table summarizes LINC02499 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02499. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02499 shows lower tumor expression in KIRC, KIRP, KICH and CHOL and higher tumor expression in LUSC and HNSC. The KIRC box plot shows higher LINC02499 RNA expression in normal versus tumor tissue (log2 FC = −1.167, t-test p < 0.001).
This table shows molecular features associated with LINC02499 in patient tissues and cancer cell lines. In patient samples, LINC02499 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
